• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
    All News #Library
    Biotech

    Marker Therapeutics & Cellipont Bioservice Collaborate for MT-601

    GLOBENEWSWIRE

    BioAegis Receives FDA Fast Track Designation for Lead Product

    GLOBENEWSWIRE

    Draig Launches with $140M for Neuropsychiatric Disorders

    GLOBENEWSWIRE

    In competitive HAE market, CSL gains FDA approval for Andembry

    FIERCE PHARMA

    Ventyx Biosciences Reports Positive Phase 2a Data on VTX3232

    GLOBENEWSWIRE

    Immuneering Sees 94% Survival at 6 Months in Pancreatic Cancer

    FIERCE BIOTECH

    Orion, Glykos Extend Pact For Next-Gen ADC Development

    PRESS RELEASE

    Mineralys Drug Lowers Blood Pressure in Yet Another Clinical Win

    FIERCE BIOTECH

    CEO props up Aptose`s Finances to Prevent Biotech from Going Bust

    FIERCE BIOTECH

    US biotechs must adapt as global competition rises: Antares CEO

    FIERCE BIOTECH

    Cantargia secures SEK 50M financing, extends cash runway to 2026

    ACCESSWIRE

    Moolec Closes Merger, Expands In Life Sciences, Food-Tech

    ACCESSWIRE

    Tharimmune Names James Liddy To Board, Adds Leadership

    ACCESSWIRE

    NAYA Expands HCC Pipeline With GPC3 Astatine-211 Therapy

    ACCESSWIRE

    Astrocyte Pharmaceuticals Hits Milestones: Phase 2 Trial, $3M NIH

    GLOBENEWSWIRE

    Skye Bioscience to Present Preclinical CB1 Antibody Data

    GLOBENEWSWIRE

    Eccogene Shows ECC4703 Combos Spare Muscle, Burn Fat

    GLOBENEWSWIRE

    Lisata Therapeutics, GATC Health Expand AI-Driven Drug Discovery

    GLOBENEWSWIRE

    Maxion Appoints Dr. Stefan As Chief Development Officer

    GLOBENEWSWIRE

    Ashvattha Therapeutics to Present Novel Nanomedicine Radiotracers

    GLOBENEWSWIRE

    IMUNON`s PlaCCine® DNA Vaccine Abstract Selected for Oral Present

    GLOBENEWSWIRE

    FOXO`s Hospital Launches New Wound Care Service Offering

    GLOBENEWSWIRE

    Lipella Pharmaceuticals Announces U.S. Patent for Diagnostic Tech

    GLOBENEWSWIRE

    Omada GLP-1 Track Shows Weight, Drug Persistence Gains

    GLOBENEWSWIRE

    BioAge Expands Platform Using Leading EU Biobank Data

    GLOBENEWSWIRE

    Cardiff Oncology Names Dr. Roger Sidhu Chief Medical Officer

    GLOBENEWSWIRE

    Serina Therapeutics Congratulates Juvenescence on $76M Series B

    GLOBENEWSWIRE

    Exobiosphere, SCU Launch High-Throughput Space Biotech

    PR NEWSWIRE

    HanchorBio Presents Data on HCB101 Checkpoint Inhibitor at ASCO

    PR NEWSWIRE

    Integral Molecular Out-Licenses Antibody Panel Targeting SLC2A4

    PR NEWSWIRE

    LSOMS Holdings Completes First Acquisition, Enhancing Compliance

    PR NEWSWIRE

    Arialys Shows ART5803 Efficacy In Autoimmune Disorder

    BUSINESSWIRE

    Arima Genomics Appoints Tom Willis as CEO, Closes $22M Series C

    BUSINESSWIRE

    Hera Biotech Buys HeraFem, Unveils 91% Cervical Cancer Test

    BUSINESSWIRE

    Mikin Patel, MD & Osman Ahmed, MD Join Joint & Vascular Institute

    BUSINESSWIRE

    Veranova, Enzene unveil separate biologics expansions in US

    FIERCE BIOTECH

    NextCure Joins China-ADC Gold Rush with $745M Simcere Deal

    BIOSPACE

    Regeneron Backs Off 23andMe, Losing Bid to Former CEO

    BIOSPACE

    Eli Lilly nears $1.3 Billion Deal for Verve Therapeutics

    REUTERS

    Roche Advances Prasinezumab to Ph3 in Parkinson’s Disease

    GLOBENEWSWIRE

    Roche Shares Elevidys Safety Update in Non-Amb DMD Patients

    GLOBENEWSWIRE

    Talvey + Tecvayli Combo Shows Deep Responses in Myeloma

    GLOBENEWSWIRE

    Verekitug, a Novel Antibody Antagonist, Shows Potent Mechanism

    GLOBENEWSWIRE

    Dupixent Beats Xolair in Ph4 Nasal Polyp Study at EAACI 2025

    PRESS RELEASE

    Genmab`s Epcoritamab Combo Shows High Response in DLBCL

    BUSINESSWIRE

    Talvey and Tecvayli Combo Effective in Multiple Myeloma Patients

    PR NEWSWIRE

    Samsung Biologics Launches Drug Screening Services, Organoids

    PR NEWSWIRE

    Celltrion Gets FDA Approval for more Steqeyma Dosing Options

    PR NEWSWIRE

    ASCO 2025: Cadonilimab Data in Advanced Cervical Cancer

    PR NEWSWIRE

    Innovent Begins 7th Ph3 Trial of Mazdutide in China

    PR NEWSWIRE

    Jasper Reports Strong Data for Briquilimab in SPOTLIGHT Trial

    GLOBENEWSWIRE

    Celldex Barzolvolimab Shows Long-Term Benefit in Urticaria

    GLOBENEWSWIRE

    Keytruda`s Novel Head and Neck Cancer Nod Comes with A Limit

    BUSINESSWIRE

    AstraZeneca Signs AI Research Deal with CSPC for Chronic Disease

    REUTERS

    US FDA Approves UroGen’s Zusduri for Bladder Cancer

    BUSINESSWIRE

    Bavarian Nordic Initiates Ph 3 of Chikungunya Vaccine in Children

    GLOBENEWSWIRE

    GSK Offloads Shigella Vaccine to Bharat Biotech Ahead of Phase 3

    PRESS RELEASE

    BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal

    FIERCE BIOTECH

    BMS Taps Biotech Analyst to Lead Long-Term Strategy

    FIERCE BIOTECH

    J&J Lymphoma CAR-T hits 100% ORR in 10 patients

    FIERCE BIOTECH

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.